$30.6MRank #1153 on ASXHealthcareMedical - Devices
Prices updated 23 June 2026, 4:40 am AEST · Data: Financial Modeling Prep
Market Cap
$30.6M
Volume
184K
P/E Ratio
-2.79
EPS
-$0.0118
Dividend Yield
0.00%
52-Week High
$0.205
52-Week Low
$0.10
Beta
0.921
Nova Eye Medical (ASX: EYE) is an Australian-listed company in the Healthcare sector with a market capitalisation of $30.6M and the 1153rd-largest security on the ASX by market capitalisation. The EYE share price is $0.1075, down 2.27% today and down 4.35% over the past 12 months. Shares have traded between $0.10 and $0.205 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Nova Eye Medical reported revenue of $16.7M and a net loss of $3.4M.
Charts
$0.11
24H Range
$0.107
$0.11
52-Week Range
$0.10
$0.205
About Nova Eye Medical Limited
Nova Eye Medical Limited specializes in the creation, advancement, distribution, marketing, sale, and servicing of surgical equipment dedicated to treating glaucoma. Its diverse product line features iTrack, a surgical system engineered to decrease intraocular pressure (IOP) in adult patients with open-angle glaucoma, and iTrack Advance, an innovative system promoting natural ocular fluid drainage. Furthermore, the company provides Molteno3, a glaucoma drainage device for individuals suffering from severe or intricate forms of the condition, alongside 2RT, a proprietary laser technology employed to address early to intermediate stages of age-related macular degeneration. With a presence spanning Australia, the United States, Europe, the Asia Pacific, and other international markets, the company, originally established in 1985 as Ellex Medical Lasers Limited, officially became Nova Eye Medical Limited in July 2020. Its corporate headquarters are situated in Kent Town, Australia.
What is the Nova Eye Medical (ASX: EYE) share price?
The EYE share price is $0.1075, down 2.27% for the day, based on the latest available ASX market data.
What is Nova Eye Medical's market capitalisation?
Nova Eye Medical has a market capitalisation of $30.6M, making it the 1153rd-largest security listed on the ASX.
Does Nova Eye Medical pay a dividend?
EYE does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is Nova Eye Medical profitable?
In its most recent reported period (ending 31 Dec 2025), EYE reported revenue of $16.7M and a net loss of $3.4M.
How many EYE shares are on issue?
Nova Eye Medical has approximately 284,868,000 shares on issue, based on its market capitalisation of $30.6M and current share price.
What sector is Nova Eye Medical in?
Nova Eye Medical is classified in the Healthcare sector, within the Medical - Devices industry on the ASX.
When did Nova Eye Medical list on the ASX?
Nova Eye Medical listed on the Australian Securities Exchange on 26 July 1999.
